News | March 17, 2010

Two-Week Break in Radiation Therapy Offers a Safe Option

March 17, 2010 - Researchers found a two-week break in radiation therapy for patients with stage I small cell lung cancer, who have gone through surgery, reduced patients' symptoms without adversely affecting cancer survival, reports the February issue of the Journal of Thoracic Oncology.

While the majority of lung cancer patients present with locally advanced or stage IV disease, the primary challenge in treating them is that most present with poor performance status, and the benefit of treatment may be doubtful because of poor tolerance to any form of therapy.

Palliative chest radiotherapy for lung malignancies has shown to be effective in relieving serious chest symptoms from tumor bleeding or mass effect on major airways, vessels and nerves. However, there is a lack of consensus for an optimal palliative RT regimen.

Researchers sought to assess the overall efficacy of split-course palliative chest RT for symptom relief in patients with advanced non-small cell lung cancer. Additionally, researchers investigated the impact the regimen’s two-week break has on survival outcomes.

Investigators reviewed the records of 140 patients treated between 1995 and 2006, who were prescribed to an initial 25 Gy in 10 fractions through anterior-posterior/posterior-anterior beam arrangements. After two weeks of rest, selected patients were given an additional 10 Gy (anterior-posterior/posterior-anterior) followed by off-cord beams to a final dose of 50 to 62.5 Gy.

Symptomatic relief was observed in 52 to 84 percent of patients with durable palliation in 58 percent. The researchers observed: "The built-in two-week break allowed for selection of patients for high-dose palliative radiation and balanced treatment benefits with potential side effects. Cancer survival was not adversely affected by treatments in this population with mostly advanced disease." The researchers added that the two-week break may be an option for patients who cannot tolerate an uninterrupted course.

Reference: Metcalfe, Su K.; Milano, Michael T.; Bylund, Kevin; Smudzin, Therese; Rubin, Philip; Chen, Yuhchyau. Split-Course Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(2):185-190, February 2010.

For more information:

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation